125 related articles for article (PubMed ID: 27478135)
1. The effects of dose and diet on the pharmacokinetics of omeprazole in the horse.
Sykes BW; Underwood C; McGowan CM; Mills PC
J Vet Pharmacol Ther; 2017 Apr; 40(2):172-178. PubMed ID: 27478135
[TBL] [Abstract][Full Text] [Related]
2. The effects of dose and diet on the pharmacodynamics of omeprazole in the horse.
Sykes BW; Underwood C; Greer R; McGowan CM; Mills PC
Equine Vet J; 2017 Jul; 49(4):525-531. PubMed ID: 27554924
[TBL] [Abstract][Full Text] [Related]
3. The effect of feeding on the pharmacokinetic variables of two commercially available formulations of omeprazole.
Sykes BW; Underwood C; McGowan CM; Mills PC
J Vet Pharmacol Ther; 2015 Oct; 38(5):500-3. PubMed ID: 25676888
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of intravenous, plain oral and enteric-coated oral omeprazole in the horse.
Sykes BW; Underwood C; McGowan CM; Mills PC
J Vet Pharmacol Ther; 2015 Apr; 38(2):130-6. PubMed ID: 25271390
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of oral omeprazole in llamas.
Poulsen KP; Smith GW; Davis JL; Papich MG
J Vet Pharmacol Ther; 2005 Dec; 28(6):539-43. PubMed ID: 16343286
[TBL] [Abstract][Full Text] [Related]
6. Disposition of the anti-ulcer medications ranitidine, cimetidine, and omeprazole following administration of multiple doses to exercised Thoroughbred horses.
Knych HK; Stanley SD; Arthur RM; McKemie DS
J Vet Pharmacol Ther; 2017 Jan; 40(1):92-96. PubMed ID: 27292271
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of intrarectal omeprazole in alpacas.
Marmulak T; Stanley S; Kass PH; Wiebe V; McKemie D; Pusterla N
J Vet Pharmacol Ther; 2010 Aug; 33(4):371-5. PubMed ID: 20646199
[TBL] [Abstract][Full Text] [Related]
8. A pharmacokinetic study comparing single and repeated oral doses of 20 mg and 40 mg omeprazole and its two optical isomers, S-omeprazole (esomeprazole) and R-omeprazole, in healthy subjects.
Hassan-Alin M; Andersson T; Niazi M; Röhss K
Eur J Clin Pharmacol; 2005 Jan; 60(11):779-84. PubMed ID: 15578172
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of orally administered omeprazole in children. International Pediatric Omeprazole Pharmacokinetic Group.
Andersson T; Hassall E; Lundborg P; Shepherd R; Radke M; Marcon M; Dalväg A; Martin S; Behrens R; Koletzko S; Becker M; Drouin E; Göthberg G
Am J Gastroenterol; 2000 Nov; 95(11):3101-6. PubMed ID: 11095324
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and tolerability of a new formulation of omeprazole in the horse.
Di Salvo A; Busechian S; Zappulla F; Marchesi MC; Pieramati C; Orvieto S; Boveri M; Predieri PG; Rueca F; Della Rocca G
J Vet Pharmacol Ther; 2017 Aug; 40(4):348-355. PubMed ID: 27885694
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and bioequivalence testing of five commercial formulations of omeprazole in the horse.
Sykes BW; Underwood C; Greer R; McGowan CM; Mills PC
J Vet Pharmacol Ther; 2016 Feb; 39(1):78-83. PubMed ID: 25989292
[TBL] [Abstract][Full Text] [Related]
12. The effects of dose and diet on the pharmacodynamics of esomeprazole in the horse.
Sykes BW; Underwood C; Mills PC
Equine Vet J; 2017 Sep; 49(5):637-642. PubMed ID: 28117490
[TBL] [Abstract][Full Text] [Related]
13. Bioequivalence assessment of two capsule formulations of omeprazole in healthy volunteers.
Hussein RF; Lockyer M; Hammami MM
Arzneimittelforschung; 2007; 57(2):101-5. PubMed ID: 17396620
[TBL] [Abstract][Full Text] [Related]
14. The bioavailability of bromazepam, omeprazole and paracetamol given by nasogastric feeding tube.
Podilsky G; Berger-Gryllaki M; Testa B; Buclin T; Roulet M; Pannatier A
Eur J Clin Pharmacol; 2009 May; 65(5):435-42. PubMed ID: 19189088
[TBL] [Abstract][Full Text] [Related]
15. Lack of pharmacokinetic interaction between omeprazole or lansoprazole and ivabradine in healthy volunteers: an open-label, randomized, crossover, pharmacokinetic interaction clinical trial.
Portolés A; Calvo A; Terleira A; Laredo L; Resplandy G; Gorostiaga C; Moreno A
J Clin Pharmacol; 2006 Oct; 46(10):1195-203. PubMed ID: 16988209
[TBL] [Abstract][Full Text] [Related]
16. Variable omeprazole kinetics in healthy Jordanian adults.
Albsoul-Younes A; Tayyem R; Najib N
Biopharm Drug Dispos; 2005 Jul; 26(5):183-8. PubMed ID: 15906422
[TBL] [Abstract][Full Text] [Related]
17. Influence of food on the bioavailability of an enteric-coated tablet formulation of omeprazole 20 mg under repeated dose conditions.
Thomson AB; Sinclair P; Matisko A; Rosen E; Andersson T; Olofsson B
Can J Gastroenterol; 1997; 11(8):663-7. PubMed ID: 9459045
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics during treatment with the omeprazole 20 mg enteric-coated tablet and 20 mg capsule in asymptomatic duodenal ulcer patients.
Thomson AB; Kirdeikis P; Lastiwka R; Röhss K; Sinclair P; Olofsson B
Can J Gastroenterol; 1997; 11(8):657-60. PubMed ID: 9459044
[TBL] [Abstract][Full Text] [Related]
19. Bioequivalence between omeprazole MUPS 20 mg as tablet and omeprazole MUPS 20 mg as tablet encapsulated in a hard gelatine capsule.
Schaltenbrand R; Huber R; Cotoraci CA; Mascher H; Potthast H; Hole U
Int J Clin Pharmacol Ther; 2001 Oct; 39(10):453-9. PubMed ID: 11680670
[TBL] [Abstract][Full Text] [Related]
20. Comparison of paste and suspension formulations of omeprazole in the healing of gastric ulcers in racehorses in active training.
Nieto JE; Spier S; Pipers FS; Stanley S; Aleman MR; Smith DC; Snyder JR
J Am Vet Med Assoc; 2002 Oct; 221(8):1139-43. PubMed ID: 12387383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
